Prostate Cancer

Author:
Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute
Search for other papers by Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute in
Current site
Google Scholar
PubMed
Close
Full access

To properly identify and treat patients with prostate cancer, physicians must have an in-depth understanding of the natural history and diagnostic, staging, and treatment options. Prostate cancer is a complex disease, with many controversial aspects of management and a dearth of sound data to support recommendations. Several variables must be considered in tailoring prostate cancer therapy to each individual patient. These guidelines provide a framework on which to base treatment decisions. Important changes to the guidelines since last publication include the introduction of Principles of Life Expectancy Estimation table and changes in recommendations for both hormone and chemotherapy.

For the most recent version of the guidelines, please visit NCCN.org

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) is a national and international leader in cancer prevention, detection and treatment. Through partnership with the NCCN and a broad and growing array of scientists and research institutions worldwide, OSUCCC-James physicians and scientists focus on basic, clinical and applied research to improve patients' lives and lessen the burden of cancer around the globe.

The Ohio State University Comprehensive Cancer Center (OSUCCC) is one of only 39 NCI-designated Comprehensive Cancer Centers in the country, a status it has maintained for more than 30 years. It has seven interdisciplinary cancer research programs comprising more than 265 researchers in 14 different colleges at the University. Annual direct and indirect grant funding totals more than $120 million, including more than $51 million from the National Cancer Institute.

The James Cancer Hospital and Solove Research Institute (The James) is the adult patient care component of Ohio State's Comprehensive Cancer Center and one of only 10 freestanding cancer hospitals in the nation. Since opening in 1990, The James has successfully treated thousands of cancer patients from all 50 states and nearly 20 countries from around the world. In addition, The James has consistently been ranked as one of America's Best Hospitals for cancer care by U.S. News & World Report since 1999.

Pictured on the cover are (from top): Michael Caligiuri, MD, director of the Ohio State University Comprehensive Cancer Center and internationally renowned expert in immunity and hematologic malignancies; David Schuller, MD, CEO of The James Cancer Hospital and Solove Research Institute and internationally renowned expert in head and neck cancers; and Dennis Smith, executive director of The James Cancer Hospital and Solove Research Institute and chair of the Alliance of Dedicated Cancer Centers.

  • Collapse
  • Expand

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 414 164 46
PDF Downloads 103 17 5
EPUB Downloads 0 0 0